| Literature DB >> 26436548 |
Katherine Mifflin, Curtis Benson, Bradley Kerr, Feyza Aricioglu, Mesut Cetin, Serdar Dursun, Glen Baker.
Abstract
Comorbidity between major depressive disorder (MDD), anxiety (generalized anxiety, panic disorder, social anxiety disorder) and pain is a major complicating factor in the diagnosis and treatment of psychiatric and neurological disorders. Although numerous neurotransmitters and/or neuromodulators may be involved, abnormalities in the GABAergic and glutamatergic systems seem to be a common factor in all these disorders. Neuroactive steroids (NASs) have been the object of considerable interest in this area in recent years since they appear to act predominantly on GABA-A and glutamate NMDA receptors. An overview of the possible involvement of NASs in MDD, anxiety and pain is provided in this chapter.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26436548 DOI: 10.1159/000435935
Source DB: PubMed Journal: Mod Trends Pharmacopsychiatry ISSN: 0077-0094